Assessment
Questionnaire
See what questions
a doctor would ask.
Temozolomide: An anticancer drug that belongs to the family of drugs called alkylating agents.
Source: National Institute of Health
Temozolomide: An orally bioavailable triazene analog of dacarbazine with antineoplastic activity. As a cytotoxic alkylating agent, temozolomide is converted at physiologic pH to the short-lived active compound monomethyl triazeno imidazole carboxamide (MTIC); MTIC's cytotoxicity is due primarily to methylation of DNA at the O6 and N7 positions of guanine, which inhibits DNA replication. Unlike dacarbazine, which is metabolized to MITC only in the liver, temozolomide is metabolized to MITC at all sites. Temozolomide penetrates well into the central nervous system. (NCI04)
Source: Diseases Database
Temozolomide: dacarbazine derivative; alkylating antineoplastic agent.
Source: CRISP
These medical condition or symptom topics may be relevant to medical information for Temozolomide:
Source - CRISP
Source: CRISP
Source: CRISP
Source: Diseases Database
Search to find out more about Temozolomide:
|
Search Specialists by State and City
By using this site you agree to our Terms of Use. Information provided on this site is for informational purposes only; it is not intended as a substitute for advice from your own medical team. The information on this site is not to be used for diagnosing or treating any health concerns you may have - please contact your physician or health care professional for all your medical needs. Please see our Terms of Use.
Copyright © 2011 Health Grades Inc. All rights reserved. Last Update: 7 May, 2013 (1:19)